Cell-mediated and humoral immune responses after vaccination with a 3-antigen HBV vaccine containing pre-S1, pre-S2, and S antigens, compared to a single-antigen HBV vaccine: Results from a pivotal phase III, randomized clinical trial (PROTECT)

Conference: American Association for the Study of Liver Disease (AASLD) - The Liver Meeting® 2021
Date: November 12, 2021